Madeleine Scott
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Madeleine Scott has a total of 38 co-authors. Here are the top co-authors by number of shared publications:
Alejandro Lopez-Ramirez
Buck Institute for Research on Aging, Novato, CA, USA
1 shared publication- Amit A. Upadhyay
Emory Vaccine Center, Yerkes National Primate Research Center, Atlanta, Georgia, USA
1 shared publication - Ashley Loureiro
Buck Institute for Research on Aging, Novato, CA, USA
1 shared publication - Bali Pulendran
Institute for Immunity, Transplantation and Infection, Stanford University School of Medicine, Stanford University, Stanford, USA
1 shared publication Birgit Schilling
Buck Institute for Research on Aging, Novato, CA, USA
1 shared publication- Chris Ka Pun Mok
The Chinese University of Hong Kong
1 shared publication
Latest Publications
- Open Access
- 19 December 2023
- Published by Elsevier in Brain Research
- Vol. 1826, 148733
Brain transcriptomic, metabolic and mitohormesis properties associated with N-propargylglycine treatment: A prevention strategy against neurodegeneration
- 19 December 2023
- Published by Elsevier in Brain Research
- Vol. 1826, 148733
Open AccessBrain transcriptomic, metabolic and mitohormesis properties associated with N-propargylglycine treatment: A prevention strategy against neurodegeneration
- Top Cited PapersOpen Access
- 4 September 2020
- Published by American Association for the Advancement of Science (AAAS) in Science
- Vol. 369 (6508) , 1210-1220
Systems biological assessment of immunity to mild versus severe COVID-19 infection in humans
Immune profiling of COVID-19 patients: Coronavirus disease 2019 (COVID-19) has affected millions of people globally, yet how the human immune system responds to and influences COVID-19 severity remains unclear. Mathewet al.present a comprehensive atlas of immune modulation associated with COVID-19. They performed high-dimensional flow cytometry of hospitalized COVID-19 patients and found three prominent and distinct immunotypes that are related to disease severity and clinical parameters. Arunachalamet al.report a systems biology approach to assess the immune system of COVID-19 patients with mild-to-severe disease. These studies provide a compendium of immune cell information and roadmaps for potential therapeutic interventions.Science, this issue p.eabc8511, p.1210
- 4 September 2020
- Published by American Association for the Advancement of Science (AAAS) in Science
- Vol. 369 (6508) , 1210-1220
Top Cited PapersOpen AccessSystems biological assessment of immunity to mild versus severe COVID-19 infection in humans
Immune profiling of COVID-19 patients: Coronavirus disease 2019 (COVID-19) has affected millions of people globally, yet how the human immune system responds to and influences COVID-19 severity remains unclear. Mathewet al.present a comprehensive atlas of immune modulation associated with COVID-19. They performed high-dimensional flow cytometry of hospitalized COVID-19 patients and found three prominent and distinct immunotypes that are related to disease severity and clinical parameters. Arunachalamet al.report a systems biology approach to assess the immune system of COVID-19 patients with mild-to-severe disease. These studies provide a compendium of immune cell information and roadmaps for potential therapeutic interventions.Science, this issue p.eabc8511, p.1210